Zydus Wellness Designated Person Acquires 507 Equity Shares Worth ₹1.99 Lakh
Zydus Wellness Limited disclosed that Designated Person Vineet Shrivastava acquired 507 equity shares worth ₹1,99,504.50 from the open market on NSE on February 26, 2026. The transaction was reported under SEBI PIT Regulations, with the company filing Form B with stock exchanges on March 2, 2026. Despite the acquisition, Shrivastava's shareholding percentage remains at 0.00% of total equity.
*this image is generated using AI for illustrative purposes only.
Zydus Wellness Limited has disclosed an insider trading transaction involving the acquisition of 507 equity shares by one of its Designated Persons. The company filed the mandatory disclosure with stock exchanges on March 2, 2026, in compliance with SEBI regulations.
Transaction Details
The acquisition was made by Vineet Shrivastava, a Designated Person at Zydus Wellness Limited, who purchased the shares from the open market on February 26, 2026. The transaction details are presented below:
| Parameter: | Details |
|---|---|
| Acquirer: | Vineet Shrivastava (Designated Person) |
| Number of Shares: | 507 equity shares |
| Share Value: | ₹2 per share |
| Total Transaction Value: | ₹1,99,504.50 |
| Transaction Date: | February 26, 2026 |
| Exchange: | National Stock Exchange (NSE) |
| Mode: | Open market acquisition |
Shareholding Position
Prior to this transaction, Vineet Shrivastava held zero equity shares in Zydus Wellness Limited. Following the acquisition of 507 shares, his shareholding remains at 0.00% of the total equity, indicating the relatively small size of the transaction compared to the company's total share capital.
| Shareholding Status: | Before Transaction | After Transaction |
|---|---|---|
| Number of Shares: | 0 | 507 |
| Percentage Holding: | 0.00% | 0.00% |
| Security Type: | Equity Shares | Equity Shares |
Regulatory Compliance
The transaction was reported to Zydus Wellness Limited on February 27, 2026, one day after the acquisition. The company subsequently filed the disclosure with both BSE (Code: 531335) and NSE (Code: ZYDUSWELL) on March 2, 2026, using the prescribed Form B under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.
The disclosure was signed by Nandish P. Joshi, Company Secretary & Compliance Officer of Zydus Wellness Limited, ensuring proper adherence to regulatory requirements. The filing confirms that no derivative trading was involved in this transaction, with all relevant sections marked as 'N.A.' in the disclosure form.
17
